| abstract |
The present invention relates to the use of benzoindazole derivatives, salts and solvates thereof for the preparation of a medicament that modulates the α 2 subtype GABA A receptor. The present invention further relates to a novel heterocyclic compound and a pharmaceutical composition containing the compound. Moreover, the present invention relates to compounds of formula (I), salts thereof and the preparation thereof for the preparation of a medicament for the treatment of depression, anxiety disorders, mental disorders, learning or cognitive disorders, sleep disorders, convulsive or seizure disorders, or pain It relates to the use of solvates. |